Scott Howell on the Very Large Costs of Drug Utilization Management
Listen now
Description
Health Affairs Editor-in-Chief Alan Weil interviews Scott Howell, chief strategy officer of US pharmaceuticals at Novartis Pharmaceuticals on drug utilization management and the tension between drug manufacturers and pharmaceutical benefit designs.
More Episodes
Listen to Health Affairs Editor-in-Chief Alan Weil interview Sara Kornfield, assistant professor of psychiatry at the University of Pennsylvania, on the relationship between COVID-19, postpartum depression, and mother-infant bonding.
Published 10/26/21
Health Affairs Editor-in-Chief Alan Weil interviews Isabel Morgan, director of the the Birth Equity Research Scholars Program at the National Birth Equity Collaborative, on the affects of structural racism on black birthing people's mental health and how we can do better.
Published 10/19/21
Listen to Health Affairs Editor-in-Chief, Alan Weil, interview Jennifer Moore, founding executive director of the Institute for Medicaid Innovation, on perinatal mental health, what we know about it, and what policy option exist to improve it.
Published 10/12/21